Afatinib helped overcome subsequent resistance to osimertinib in a patient with NSCLC having leptomeningeal metastasis baring acquired EGFR L718Q mutation: a case report

RT @oncologician: Lit. search showed a similar case where EGFR exon 18 L718Q was the resistance mutn acquired post Osimertinib which explai…

Lit. search showed a similar case where EGFR exon 18 L718Q was the resistance mutn acquired post Osimertinib which explains the efficacy of Afatinib to this uncommon EGFR mutation. https://t.co/FNReu1IL6O q https://t.co/qGn970pClF

Afatinib helped overcome subsequent resistance to osimertinib in a patient with NSCLC having leptomeningeal metastasis baring acquired EGFR L718Q mutation: a case report https://t.co/8JyUN9GDUf